245 related articles for article (PubMed ID: 1678520)
1. A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps.
Gros P; Dhir R; Croop J; Talbot F
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7289-93. PubMed ID: 1678520
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of P-glycoprotein mutants identifies predicted transmembrane domain 11 as a putative drug binding site.
Kajiji S; Talbot F; Grizzuti K; Van Dyke-Phillips V; Agresti M; Safa AR; Gros P
Biochemistry; 1993 Apr; 32(16):4185-94. PubMed ID: 7682843
[TBL] [Abstract][Full Text] [Related]
3. Modulatory effects on substrate specificity of independent mutations at the serine939/941 position in predicted transmembrane domain 11 of P-glycoproteins.
Dhir R; Grizzuti K; Kajiji S; Gros P
Biochemistry; 1993 Sep; 32(36):9492-9. PubMed ID: 8103679
[TBL] [Abstract][Full Text] [Related]
4. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities.
Devault A; Gros P
Mol Cell Biol; 1990 Apr; 10(4):1652-63. PubMed ID: 1969610
[TBL] [Abstract][Full Text] [Related]
5. Functional consequences of proline mutations in the predicted transmembrane domain of P-glycoprotein.
Loo TW; Clarke DM
J Biol Chem; 1993 Feb; 268(5):3143-9. PubMed ID: 8094081
[TBL] [Abstract][Full Text] [Related]
6. Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance.
Azzaria M; Schurr E; Gros P
Mol Cell Biol; 1989 Dec; 9(12):5289-97. PubMed ID: 2573836
[TBL] [Abstract][Full Text] [Related]
7. Human (MDR1) and mouse (mdr1, mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators.
Tang-Wai DF; Kajiji S; DiCapua F; de Graaf D; Roninson IB; Gros P
Biochemistry; 1995 Jan; 34(1):32-9. PubMed ID: 7819214
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of chimeric proteins constructed by exchanging homologous domains of two P-glycoproteins conferring distinct drug resistance profiles.
Dhir R; Gros P
Biochemistry; 1992 Jul; 31(26):6103-10. PubMed ID: 1352702
[TBL] [Abstract][Full Text] [Related]
9. Structurally distinct MDR modulators show specific patterns of reversal against P-glycoproteins bearing unique mutations at serine939/941.
Kajiji S; Dreslin JA; Grizzuti K; Gros P
Biochemistry; 1994 May; 33(17):5041-8. PubMed ID: 8172879
[TBL] [Abstract][Full Text] [Related]
10. An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene.
Choi KH; Chen CJ; Kriegler M; Roninson IB
Cell; 1988 May; 53(4):519-29. PubMed ID: 2897240
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional characterization of the mouse multidrug resistance gene family.
Dhir R; Buschman E; Gros P
Bull Cancer; 1990; 77(11):1125-9. PubMed ID: 1980424
[TBL] [Abstract][Full Text] [Related]
12. Mutagenesis of transmembrane domain 11 of P-glycoprotein by alanine scanning.
Hanna M; Brault M; Kwan T; Kast C; Gros P
Biochemistry; 1996 Mar; 35(11):3625-35. PubMed ID: 8639515
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185----Val-185 substitution in P-glycoprotein.
Safa AR; Stern RK; Choi K; Agresti M; Tamai I; Mehta ND; Roninson IB
Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7225-9. PubMed ID: 1976255
[TBL] [Abstract][Full Text] [Related]
14. Functional consequences of phenylalanine mutations in the predicted transmembrane domain of P-glycoprotein.
Loo TW; Clarke DM
J Biol Chem; 1993 Sep; 268(27):19965-72. PubMed ID: 8104183
[TBL] [Abstract][Full Text] [Related]
15. The nitrogen of the acetamido group of colchicine modulates P-glycoprotein-mediated multidrug resistance.
Tang-Wai DF; Brossi A; Arnold LD; Gros P
Biochemistry; 1993 Jun; 32(25):6470-6. PubMed ID: 8100149
[TBL] [Abstract][Full Text] [Related]
16. Sequence of mdr3 cDNA encoding a human P-glycoprotein.
van der Bliek AM; Kooiman PM; Schneider C; Borst P
Gene; 1988 Nov; 71(2):401-11. PubMed ID: 2906314
[TBL] [Abstract][Full Text] [Related]
17. Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters.
Currier SJ; Kane SE; Willingham MC; Cardarelli CO; Pastan I; Gottesman MM
J Biol Chem; 1992 Dec; 267(35):25153-9. PubMed ID: 1360983
[TBL] [Abstract][Full Text] [Related]
18. Coordinate changes in drug resistance and drug-induced conformational transitions in altered-function mutants of the multidrug transporter P-glycoprotein.
Ruth A; Stein WD; Rose E; Roninson IB
Biochemistry; 2001 Apr; 40(14):4332-9. PubMed ID: 11284689
[TBL] [Abstract][Full Text] [Related]
19. Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells.
Raymond M; Rose E; Housman DE; Gros P
Mol Cell Biol; 1990 Apr; 10(4):1642-51. PubMed ID: 1969609
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection.
Choi K; Frommel TO; Stern RK; Perez CF; Kriegler M; Tsuruo T; Roninson IB
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7386-90. PubMed ID: 1678523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
